You're viewing a public preview of Thymmune Therapeutics, Inc. Sign up free to access full investment history, financials, executives & more
Sign Up Free Log In

Thymmune Therapeutics, Inc.

Active
215 First Street, Suite 401,  Cambridge,  Massachusetts (MA),  02142,  United States
Sector: Life Science Entity: Private Founded: 2021
2021
Founded
Year established
1
Transactions
Sign up to view
About Thymmune Therapeutics, Inc.
Thymmune Therapeutics, Inc. is a United States–based biotechnology company focused on the development of regenerative immunotherapies for immune system disorders. The company develops cell-based therapeutic approaches designed to regenerate thymus function and restore immune competence in patients with congenital, acquired, and age-related immune deficiencies. Thymmune Therapeutics conducts research and development activities spanning preclinical and clinical-stage programs, supporting the advancement of regenerative medicine technologies for immunological diseases. The company operates within the biotechnology and cell therapy sector and collaborates with academic and clinical research institutions. Thymmune Therapeutics, Inc. was founded in 2021 and is headquartered in Raleigh, North Carolina, United States.
Investors
Current Investors
United Therapeutics Corp. ••••••••
Past Investors
•••••••• ••••••••
View Full Investor List
Sign up to see all current & past investors with deal dates and transaction details
Sign Up Free Log In
Investment Details
1 Transactions
Trans. IDInvestment DateExit DateInvestor(s)Deal Size (M)Seller(s)
Access 1 Transaction
Sign up to view the full investment history — dates, deal sizes, investors & sellers
Sign Up Free Log In
Thymmune Therapeutics, Inc. M&A Activity
# Company Transaction Date Close Date Sector Country
View M&A Acquisitions
Sign up to explore the full acquisition & merger history
Sign Up Free Log In
Key Executives & Professionals
View Executives & Professionals
Sign up to access board members, senior management & key contacts
Sign Up Free Log In
Frequently Asked Questions
What does Thymmune Therapeutics, Inc. do?
Thymmune Therapeutics, Inc. is a United States–based biotechnology company focused on the development of regenerative immunotherapies for immune system disorders. The company develops cell-based therapeutic approaches designed to regenerate thymus function and restore immune competence in patients
Where is Thymmune Therapeutics, Inc. headquartered?
Thymmune Therapeutics, Inc. is headquartered in Cambridge, Massachusetts (MA), United States.
When was Thymmune Therapeutics, Inc. founded?
Thymmune Therapeutics, Inc. was founded in 2021.
What sector is Thymmune Therapeutics, Inc. in?
Thymmune Therapeutics, Inc. operates in the Life Science sector.
Who are the investors in Thymmune Therapeutics, Inc.?
Current investors in Thymmune Therapeutics, Inc. include United Therapeutics Corp.. Sign up to AcquityData to view full investor details, deal dates and transaction history.
How many M&A transactions has Thymmune Therapeutics, Inc. been involved in?
Thymmune Therapeutics, Inc. has 1 transaction tracked on AcquityData. Sign up to view full investment history including dates, deal sizes, investors and sellers.

Unlock the full Thymmune Therapeutics, Inc. profile

Ownership & Investors M&A History Financials Key Executives Advisors & Lenders

Access Thymmune Therapeutics, Inc.'s complete ownership history, M&A activity, investors, advisors and executives in one connected platform.

Start Free Trial